Cerebrospinal Fluid Management Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography

List of Tables

The cerebrospinal fluid management market size is expected to reach US$ 2,892.54 million by 2030 from US$ 1,911.37 million in 2022; it is estimated to record a CAGR of 5.3% from 2022 to 2030.

The growing demand for better treatment modalities has resulted in various product developments in the last few decades. A few of the examples of recent product developments in the CSF management market are mentioned below.

In September 2022, Anuncia Medical Inc received US Food and Drug Administration (FDA) approval for its ReFlow System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid disorders that require shunting. ReFlow System Mini noninvasively facilitates a flush of ventricular catheters to restore, increase, or maintain CSF flow in a shunt.

In March 2021, the FDA granted a breakthrough device designation for the ReFlow System of Anuncia for CSF management. The device is designed to treat CSF disorders such as hydrocephalus, which require shunting. ReFlow system can be used in homecare settings and in clinics for prophylactic flushing that is performed noninvasively to potentially prevent CSF blockages.

In June 2020, the FDA granted Breakthrough Device Designation to the FlowSense wireless, noninvasive flow sensor offered by Rhaeos, Inc. The product is designed to rapidly monitor ventricular shunt function in patients with excess cerebrospinal fluid caused by hydrocephalus.

Increasing Focus on CSF Management in Neurological Disease Treatments Provides New Opportunities for the Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

The cerebrospinal fluid management market is segments into product and end user. Based on product, the market is bifurcated into CSF shunts and CSF drainage systems. In 2022, the CSF shunts segment held the largest share of the market by product. and the same segment is estimated to grow at a significant CAGR during the forecast period due to growing product launches, increasing demand for advanced CSF shunts, and increasing incidences of hydrocephalus. CSF shunts was further segmented into ventriculoperitoneal shunts, ventriculoatrial shunts, ventriculopleural shunts, and lumboperitoneal shunts. Based on CSF shunts, ventriculoperitoneal shunts held the largest market share of cerebrospinal fluid management market and is expected to grow at a fastest CAGR during the forecast period. Similarly, the CSF drainage systems were classified into external ventricular drainage (EVD) systems and lumbar drainage (LD) systems. External ventricular drainage systems are the more commonly used CSF drainage systems in the industry therefore, marking largest share of the segment.

Based on geography, the market is segmented into North America, Europe, Asia Pacific Middle East & Africa, and South & Central America. North America held the largest market share of the cerebrospinal fluid management market. The market in North America is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure. Whereas Asia Pacific is the fastest growing region in the market owing to the factors, including growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

The growth of cerebrospinal fluid management market is defined by some of the key factors, such as increasing incidences of CSF leak and growing developments for CSF management products. On the other hand, the risk associated with CSF shunts hinders the market growth.

The Canada Communicable Disease Report (CCDR), Centers for Disease Control and Prevention (CDC), European Union, Italian Trade Agency (ITA) are a few key primary and secondary sources referred to while preparing the report on the cerebrospinal fluid management market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cerebrospinal fluid management.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global cerebrospinal fluid management, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global cerebrospinal fluid management trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00004182

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Cerebrospinal Fluid Management Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 South & Central America PEST Analysis
- 4.2.5 Middle East & Africa PEST Analysis

5. Cerebrospinal Fluid Management Market - Key Industry Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidences of CSF Leak
- 5.1.2 Growing Developments for CSF Management Products
5.2 Market Restraints
- 5.2.1 Risk Associated with CSF Shunts
5.3 Market Opportunities
- 5.3.1 Increasing Focus on Use of CSF Management for Treatment of Neurological Diseases
5.4 Future Trends
- 5.4.1 Technological Developments for CSF Shunts
5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Global Market Analysis

6.1 Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

7.1 Overview
7.2 Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
- 7.3.1 Overview
- 7.3.2 CSF Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Ventriculoperitoneal Shunts
  - 7.3.3.1 Overview
  - 7.3.3.2 Ventriculoperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Ventriculoatrial Shunts
  - 7.3.4.1 Overview
  - 7.3.4.2 Ventriculoatrial Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Ventriculopleural Shunts
  - 7.3.5.1 Overview
  - 7.3.5.2 Ventriculopleural Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Lumboperitoneal Shunts
  - 7.3.6.1 Overview
  - 7.3.6.2 Lumboperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
- 7.4.1 Overview
- 7.4.2 CSF Drainage Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 External Ventricular Drainage (EVD) Systems
  - 7.4.3.1 Overview
  - 7.4.3.2 External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Lumbar Drainage (LD) Systems
  - 7.4.4.1 Overview
  - 7.4.4.2 Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

8.1 Overview
8.2 Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
- 8.4.1 Overview
- 8.4.2 Clinics: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
- 8.5.1 Overview
- 8.5.2 Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Cerebrospinal Fluid Management Market - Geographical Analysis

9.1 North America Cerebrospinal Fluid Management Market, Revenue and Forecast To 2030
- 9.1.1 Overview
- 9.1.2 North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.1.2.1 North America Cerebrospinal Fluid Management Market, by Product
    - 9.1.2.1.1 North America Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.1.2.1.2 North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
  - 9.1.2.2 North America Cerebrospinal Fluid Management Market, by End User
  - 9.1.2.3 North America Cerebrospinal Fluid Management Market, by Country
  - 9.1.2.4 US
    - 9.1.2.4.1 Overview
    - 9.1.2.4.2 US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.2.4.3 US Cerebrospinal Fluid Management Market, by Product
    - 9.1.2.4.3.1 US Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.1.2.4.3.2 US Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.1.2.4.4 US Cerebrospinal Fluid Management Market, by End User
  - 9.1.2.5 Canada
    - 9.1.2.5.1 Overview
    - 9.1.2.5.2 Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.2.5.3 Canada Cerebrospinal Fluid Management Market, by Product
    - 9.1.2.5.3.1 Canada Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.1.2.5.3.2 Canada Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.1.2.5.4 Canada Cerebrospinal Fluid Management Market, by End User
  - 9.1.2.6 Mexico
    - 9.1.2.6.1 Overview
    - 9.1.2.6.2 Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.1.2.6.3 Mexico Cerebrospinal Fluid Management Market, by Product
    - 9.1.2.6.3.1 Mexico Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.1.2.6.3.2 Mexico Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.1.2.6.4 Mexico Cerebrospinal Fluid Management Market, by End User
9.2 Europe Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
- 9.2.1 Overview
- 9.2.2 Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.2.2.1 Europe Cerebrospinal Fluid Management Market, by Product
    - 9.2.2.1.1 Europe Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.2.2.1.2 Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
  - 9.2.2.2 Europe Cerebrospinal Fluid Management Market, by End User
  - 9.2.2.3 Europe Cerebrospinal Fluid Management Market, by Country
  - 9.2.2.4 UK
    - 9.2.2.4.1 Overview
    - 9.2.2.4.2 UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.2.4.3 UK Cerebrospinal Fluid Management Market, by Product
    - 9.2.2.4.3.1 UK Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.2.2.4.3.2 UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.2.2.4.4 UK Cerebrospinal Fluid Management Market, by End User
  - 9.2.2.5 Germany
    - 9.2.2.5.1 Overview
    - 9.2.2.5.2 Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.2.5.3 Germany Cerebrospinal Fluid Management Market, by Product
    - 9.2.2.5.3.1 Germany Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.2.2.5.3.2 Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.2.2.5.4 Germany Cerebrospinal Fluid Management Market, by End User
  - 9.2.2.6 France
    - 9.2.2.6.1 Overview
    - 9.2.2.6.2 France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.2.6.3 France Cerebrospinal Fluid Management Market, by Product
    - 9.2.2.6.3.1 France Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.2.2.6.3.2 France Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.2.2.6.4 France Cerebrospinal Fluid Management Market, by End User
  - 9.2.2.7 Italy
    - 9.2.2.7.1 Overview
    - 9.2.2.7.2 Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.2.7.3 Italy Cerebrospinal Fluid Management Market, by Product
    - 9.2.2.7.3.1 Italy Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.2.2.7.3.2 Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.2.2.7.4 Italy Cerebrospinal Fluid Management Market, by End User
  - 9.2.2.8 Spain
    - 9.2.2.8.1 Overview
    - 9.2.2.8.2 Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.2.8.3 Spain Cerebrospinal Fluid Management Market, by Product
    - 9.2.2.8.3.1 Spain Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.2.2.8.3.2 Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.2.2.8.4 Spain Cerebrospinal Fluid Management Market, by End User
  - 9.2.2.9 Rest of Europe
    - 9.2.2.9.1 Overview
    - 9.2.2.9.2 Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.2.2.9.3 Rest of Europe Cerebrospinal Fluid Management Market, by Product
    - 9.2.2.9.3.1 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.2.2.9.3.2 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.2.2.9.4 Rest of Europe Cerebrospinal Fluid Management Market, by End User
9.3 Asia Pacific Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
- 9.3.1 Overview
- 9.3.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.3.2.1 Asia Pacific Cerebrospinal Fluid Management Market, by Product
    - 9.3.2.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.3.2.1.2 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
  - 9.3.2.2 Asia Pacific Cerebrospinal Fluid Management Market, by End User
  - 9.3.2.3 Asia Pacific Cerebrospinal Fluid Management Market, by Country
  - 9.3.2.4 China
    - 9.3.2.4.1 Overview
    - 9.3.2.4.2 China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.2.4.3 China Cerebrospinal Fluid Management Market, by Product
    - 9.3.2.4.3.1 China Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.3.2.4.3.2 China Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.3.2.4.4 China Cerebrospinal Fluid Management Market, by End User
  - 9.3.2.5 Japan
    - 9.3.2.5.1 Overview
    - 9.3.2.5.2 Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.2.5.3 Japan Cerebrospinal Fluid Management Market, by Product
    - 9.3.2.5.3.1 Japan Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.3.2.5.3.2 Japan Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.3.2.5.4 Japan Cerebrospinal Fluid Management Market, by End User
  - 9.3.2.6 India
    - 9.3.2.6.1 Overview
    - 9.3.2.6.2 India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.2.6.3 India Cerebrospinal Fluid Management Market, by Product
    - 9.3.2.6.3.1 India Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.3.2.6.3.2 India Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.3.2.6.4 India Cerebrospinal Fluid Management Market, by End User
  - 9.3.2.7 Australia
    - 9.3.2.7.1 Overview
    - 9.3.2.7.2 Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.2.7.3 Australia Cerebrospinal Fluid Management Market, by Product
    - 9.3.2.7.3.1 Australia Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.3.2.7.3.2 Australia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.3.2.7.4 Australia Cerebrospinal Fluid Management Market, by End User
  - 9.3.2.8 South Korea
    - 9.3.2.8.1 Overview
    - 9.3.2.8.2 South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.2.8.3 South Korea Cerebrospinal Fluid Management Market, by Product
    - 9.3.2.8.3.1 South Korea Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.3.2.8.3.2 South Korea Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.3.2.8.4 South Korea Cerebrospinal Fluid Management Market, by End User
  - 9.3.2.9 Rest of Asia Pacific
    - 9.3.2.9.1 Overview
    - 9.3.2.9.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.3.2.9.3 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by Product
    - 9.3.2.9.3.1 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.3.2.9.3.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.3.2.9.4 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.4 Middle East & Africa Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
- 9.4.1 Overview
- 9.4.2 Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.4.2.1 Middle East & Africa Cerebrospinal Fluid Management Market, by Product
    - 9.4.2.1.1 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.4.2.1.2 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
  - 9.4.2.2 Middle East & Africa Cerebrospinal Fluid Management Market, by End User
  - 9.4.2.3 Middle East & Africa Cerebrospinal Fluid Management Market, by Country
  - 9.4.2.4 UAE
    - 9.4.2.4.1 Overview
    - 9.4.2.4.2 UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.2.4.3 UAE Cerebrospinal Fluid Management Market, by Product
    - 9.4.2.4.3.1 UAE Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.4.2.4.3.2 UAE Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.4.2.4.4 UAE Cerebrospinal Fluid Management Market, by End User
  - 9.4.2.5 Saudi Arabia
    - 9.4.2.5.1 Overview
    - 9.4.2.5.2 Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.2.5.3 Saudi Arabia Cerebrospinal Fluid Management Market, by Product
    - 9.4.2.5.3.1 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.4.2.5.3.2 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.4.2.5.4 Saudi Arabia Cerebrospinal Fluid Management Market, by End User
  - 9.4.2.6 South Africa
    - 9.4.2.6.1 Overview
    - 9.4.2.6.2 South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.2.6.3 South Africa Cerebrospinal Fluid Management Market, by Product
    - 9.4.2.6.3.1 South Africa Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.4.2.6.3.2 South Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.4.2.6.4 South Africa Cerebrospinal Fluid Management Market, by End User
  - 9.4.2.7 Rest of Middle East & Africa
    - 9.4.2.7.1 Overview
    - 9.4.2.7.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.4.2.7.3 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by Product
    - 9.4.2.7.3.1 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.4.2.7.3.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.4.2.7.4 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by End User
9.5 South & Central America Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
- 9.5.1 Overview
- 9.5.2 South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  - 9.5.2.1 South & Central America Cerebrospinal Fluid Management Market, by Product
    - 9.5.2.1.1 South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.5.2.1.2 South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
  - 9.5.2.2 South & Central America Cerebrospinal Fluid Management Market, by End User
  - 9.5.2.3 South & Central America Cerebrospinal Fluid Management Market, by Country
  - 9.5.2.4 Brazil
    - 9.5.2.4.1 Overview
    - 9.5.2.4.2 Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.5.2.4.3 Brazil Cerebrospinal Fluid Management Market, by Product
    - 9.5.2.4.3.1 Brazil Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.5.2.4.3.2 Brazil Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.5.2.4.4 Brazil Cerebrospinal Fluid Management Market, by End User
  - 9.5.2.5 Argentina
    - 9.5.2.5.1 Overview
    - 9.5.2.5.2 Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.5.2.5.3 Argentina Cerebrospinal Fluid Management Market, by Product
    - 9.5.2.5.3.1 Argentina Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.5.2.5.3.2 Argentina Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.5.2.5.4 Argentina Cerebrospinal Fluid Management Market, by End User
  - 9.5.2.6 Rest of South & Central America
    - 9.5.2.6.1 Overview
    - 9.5.2.6.2 Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
    - 9.5.2.6.3 Rest of South & Central America Cerebrospinal Fluid Management Market, by Product
    - 9.5.2.6.3.1 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
    - 9.5.2.6.3.2 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
    - 9.5.2.6.4 Rest of South & Central America Cerebrospinal Fluid Management Market, by End User

10. Pre & Post Covid-19 Impact

10.1 Pre & Post Covid-19 Impact

11. Cerebrospinal Fluid Management Market -Industry Landscape

11.1 Overview
11.2 Growth Strategies in The Cerebrospinal Fluid Management Market, 2020-2023
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Medtronic Plc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Integra LifeSciences Holdings Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B. Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Argi Group Health Services Ltd Sti
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Sophysa SA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BeckerSmith Medical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Delta Surgical Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Moller Medical GmbH
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Natus Medical Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Spiegelberg GmbH & Co KG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms